|115.22||-4.41 / -3.69%|
Data as of 4:00pm ET
|115.23||+0.01 / +0.01%|
The 15 analysts offering 12-month price forecasts for Jazz Pharmaceuticals PLC have a median target of 110.00, with a high estimate of 198.00 and a low estimate of 100.00. The median estimate represents a -4.53% decrease from the last price of 115.22.
The current consensus among 16 polled investment analysts is to Buy stock in Jazz Pharmaceuticals PLC. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.